Valens U.S. SPV I, LLC c/o Valens Capital Management, LLCBiovest International Inc • February 6th, 2008 • Pharmaceutical preparations • New York
Reference is made to the Royalty Agreement dated as of December 10, 2007 (as amended, modified or supplemented from time to time, the “Royalty Agreement”), by and between Biovest International, Inc. (the “Company”) and Valens U.S. SPV I, LLC (“Valens US”). Capitalized terms used herein that are not defined shall have the meaning given to them in the Royalty Agreement.
VALENS OFFSHORE SPV II, CORP. c/o Valens Capital Management, LLCBiovest International Inc • February 6th, 2008 • Pharmaceutical preparations • New York
Reference is made to the Royalty Agreement dated as of October 29, 2007 (as amended, modified or supplemented from time to time, the “Royalty Agreement”), by and between Biovest International, Inc. (the “Company”) and Valens Offshore SPV II, Corp. (“Valens Offshore”). Capitalized terms used herein that are not defined shall have the meaning given to them in the Royalty Agreement.
BIOVEST INTERNATIONAL, INC.Biovest International Inc • February 6th, 2008 • Pharmaceutical preparations • Florida
Reference is made to the Royalty Agreement dated as of October 31, 2006 (as amended, modified or supplemented from time to time, the “Royalty Agreement”), by and between Biovest International, Inc. (the “Company”) and Accentia Biopharmaceuticals, Inc (“Accentia”). Capitalized terms used herein that are not defined shall have the meaning given to them in the Royalty Agreement.
CONVERSION AGREEMENT BETWEEN BIOVEST INTERNATIONAL, INC. AND ACCENTIA BIOPHARMACEUTICALS, INC.Conversion Agreement • February 6th, 2008 • Biovest International Inc • Pharmaceutical preparations • Delaware
This Conversion Agreement (this “Conversion Agreement”) effective as of February 5, 2008, by and between BIOVEST INTERNATIONAL, INC., a Delaware corporation (“BIOVEST”) and ACCENTIA BIOPHARMACEUTICALS, INC., a Florida corporation, (“ACCENTIA”) (collectively the “Parties”).
